The market has been high on Johnson & Johnson (JNJ) stock recently. JNJ gets a Bullish score from InvestorsObserver’s Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.
price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What’s Happening With JNJ Stock Today?
Johnson & Johnson (JNJ) stock has gained 3.02% while the S&P 500 is lower by -0.12% as of 12:02 PM on Tuesday, Jan 26. JNJ is higher by $5.01 from the previous closing price of $165.98 on volume of 7,991,113 shares. Over the past year the S&P 500 is higher by 18.72% while JNJ is higher by 14.95%. JNJ earned $6.36 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 26.9.
To see the top 5 stocks in the Drug Manufacturers – General industry click here.
More About Johnson & Johnson
Johnson & Johnson is the world’s largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.
Click Here to get the full Stock Score Report on Johnson & Johnson (JNJ) Stock.